Caxton Associates LP Medtronic PLC Transaction History

Caxton Associates LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $2.42 Million - $2.79 Million	31,824 Added 355.58%	40,774 $3.17 Million
Q3 2022 Nov 14, 2022	SELL	$80.75 - $95.31 $897,536 - $1.06 Million	-11,115 Reduced 55.39%	8,950 $723,000
Q2 2022 Aug 15, 2022	BUY	$87.4 - $113.09 $1.75 Million - $2.27 Million	20,065 New	20,065 $1.8 Million
Q2 2019 Aug 14, 2019	SELL	$84.15 - $99.38 $909,577 - $1.07 Million	-10,809 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$82.45 - $93.79 $891,202 - $1.01 Million	10,809 New	10,809 $984,000
Q2 2018 Aug 14, 2018	SELL	$77.48 - $87.83 $1.06 Million - $1.2 Million	-13,692 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$76.55 - $87.26 $236,156 - $269,197	-3,085 Reduced 18.39%	13,692 $1.1 Million
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $736,758 - $799,679	9,577 Added 133.01%	16,777 $1.36 Million
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $23,312 - $25,380	300 Added 4.35%	7,200 $560,000
Q2 2017 Aug 29, 2017	BUY	N/A	6,900	6,900 $612,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.